<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350570</id>
  <title nil="true"/>
  <common-name>3-(1-oxo-3-phenyl-1-pyrrolidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one</common-name>
  <description>3-(1-oxo-3-phenyl-1-pyrrolidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one is a chemical compound with the formula C30H31N3O5. With an average molecular weight of 513.60 g/mol, 3-(1-oxo-3-phenyl-1-pyrrolidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one is a heavy molecule.</description>
  <cas>83409-22-7</cas>
  <pubchem-id>3068416</pubchem-id>
  <chemical-formula>C30H31N3O5</chemical-formula>
  <weight>513.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:43:11Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:43:11Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(=CC(=C1OC)OC)C2=NC3=CC=CC=C3C(=O)N2C(CC4=CC=CC=C4)C(=O)N5CCCC5</moldb-smiles>
  <moldb-formula>C30H31N3O5</moldb-formula>
  <moldb-inchi>InChI=1S/C30H31N3O5/c1-36-25-18-21(19-26(37-2)27(25)38-3)28-31-23-14-8-7-13-22(23)29(34)33(28)24(17-20-11-5-4-6-12-20)30(35)32-15-9-10-16-32/h4-8,11-14,18-19,24H,9-10,15-17H2,1-3H3</moldb-inchi>
  <moldb-inchikey>SHUOLWOYBJHIBD-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">513.2263711</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346463</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-(1-oxo-3-phenyl-1-pyrrolidin-1-ylpropan-2-yl)-2-(3,4,5-trimethoxyphenyl)quinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0300875</sync-id>
  <structure-inchikey>SHUOLWOYBJHIBD-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000000000001800000180001000000000000000000000000000000400000002040000020000400100000402004000000000000000000000000000080000000000000000000000000000000000020000000000100000000000000000000000100010000000044004200100000000000020100000000000000000000000800000040200000804000000000000000800000000100000000000000000000001000000000000000040000080000000000000000000020008000000800000080000000040000010080000000000000400000000000002000000220000000000000000000000011000040000800000400000000000020000002004000000100</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKgAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:34Z</structure-indexed-at>
</compound>
